Lupin declined 1.91% to Rs 1,990 after the pharma major said the U.S. Food and Drug Administration (FDA) conducted an inspection at its Goa manufacturing facility from 10 November to 21 November 2025.
Shilpa Medicare has announced that the U.S. Food and Drug Administration (USFDA) issued a Form 483 with eight inspectional observations for its Unit IV facility in Jadcherla, Telangana.
While the FDA has classified synthetic kratom as a public health threat and dozens of states have enacted regulations or bans ...
A new Quad Cities THC drink bar may be forced to cease operations under new federal hemp rules. Owners urge lawmakers and ...
Actor Sonali Bendre's post on autophagy helping with her cancer battle has ruffled feathers in the medical fraternity.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback